| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 1. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | liraglutide (Victoza®) |
| Formulation | 6 mg/ml solution for injection |
| Reference number | 583 |
| Indication | Treatment of type 2 diabetes mellitus to achieve glycaemic control |
| Company | Novo Nordisk Ltd |
| BNF chapter | Endocrine system |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 23/07/2009 |